Funds and ETFs Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-02-19 pm EST 5-day change 1st Jan Change
179,900 KRW -1.37% Intraday chart for Celltrion, Inc. -4.05% -10.72%

ETFs positioned on Celltrion, Inc.

Name Weight AuM 1st Jan change Investor Rating
4.14% 2 M€ -14.14%
0.99% 11 M€ -.--% -
0.53% 14 M€ +5.58%
0.18% 2,613 M€ +2.08% -
0.18% 140 M€ -0.33% -
0.18% 422 M€ +0.57% -
0.15% 4 M€ -4.41% -
0.06% 11 M€ +0.20%
0.05% 7 M€ +0.17% -
0.05% 113 M€ +0.43% -
0.04% 1 M€ +3.49% -
0.04% 3 M€ -.--% -
0.04% 0 M€ 0.00% -
0.02% 29 M€ +4.55% -
0.02% 268 M€ +2.69% -
0.02% 37 M€ +2.33% -
0.02% 341 M€ +4.20% -
0.01% 101 M€ +1.40% -
0.01% 21 M€ +0.96% -
0.01% 130 M€ +1.31% -
0.01% 50 M€ -0.19% -
0.01% 10 M€ -0.44% -
Celltrion, Inc. is a Korea-based company mainly engaged in the production and sale of biopharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Biopharmaceutical segment is involved in the manufacturing and sale of biopharmaceutical products such as multivitamins, blood circulation remedies, blood cancer treatments and breast cancer treatments. The Chemical Pharmaceutical segment is involved in the manufacturing and sale of therapeutic drugs for liver disease under the name of Godex, as well as the treatment of autoimmune diseases under the name of Remsima. The Other segment manufactures and sells other generic drugs. The Company distributes its products within the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
179,900 KRW
Average target price
222,667 KRW
Spread / Average Target
+23.77%
Consensus
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer